- Home
- CASK vs ADXN Comparison
CASK vs ADXN Comparison
Compare CASK & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASK
- ADXN
- Stock Information
- Founded
- CASK 2011
- ADXN 2002
- Country
- CASK United States
- ADXN Switzerland
- Employees
- CASK N/A
- ADXN N/A
- Industry
- CASK
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- CASK
- ADXN Health Care
- Exchange
- CASK NYSE
- ADXN Nasdaq
- Market Cap
- CASK 6.5M
- ADXN 7.5M
- IPO Year
- CASK 2024
- ADXN N/A
- Fundamental
- Price
- CASK $0.61
- ADXN $7.60
- Analyst Decision
- CASK
- ADXN Strong Buy
- Analyst Count
- CASK 0
- ADXN 1
- Target Price
- CASK N/A
- ADXN $30.00
- AVG Volume (30 Days)
- CASK 123.3K
- ADXN 8.7K
- Earning Date
- CASK 05-25-2025
- ADXN 06-05-2025
- Dividend Yield
- CASK N/A
- ADXN N/A
- EPS Growth
- CASK N/A
- ADXN N/A
- EPS
- CASK N/A
- ADXN 0.06
- Revenue
- CASK $7,522,832.00
- ADXN $701,260.00
- Revenue This Year
- CASK N/A
- ADXN N/A
- Revenue Next Year
- CASK N/A
- ADXN N/A
- P/E Ratio
- CASK $23.41
- ADXN $0.99
- Revenue Growth
- CASK N/A
- ADXN N/A
- 52 Week Low
- CASK $0.40
- ADXN $6.51
- 52 Week High
- CASK $4.00
- ADXN $17.05
- Technical
- Relative Strength Index (RSI)
- CASK N/A
- ADXN 52.85
- Support Level
- CASK N/A
- ADXN $6.75
- Resistance Level
- CASK N/A
- ADXN $8.20
- Average True Range (ATR)
- CASK 0.00
- ADXN 0.46
- MACD
- CASK 0.00
- ADXN 0.06
- Stochastic Oscillator
- CASK 0.00
- ADXN 64.50
About CASK HERITAGE DISTILLING HOLDING COMPANY INC
Heritage Distilling Holding Co Inc is a craft distiller producing, marketing and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon and by shipping directly to consumers online where legal. Currently, It sells products primarily in the Pacific Northwest with limited distribution in other states throughout the U.S.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.